Next-Generation Sequencing and Proteomics Research for Retinal Diseases

Dear Colleagues,

The retina is considered our window to the outside world. It captures, integrates, and processes visual information. The dysfunction or death of retinal photoreceptors is the major cause of vision loss, leading to several retinal diseases including age-related macular degeneration (AMD), glaucoma, and retinitis pigmentosa (RP). In recent years, Next-Generation Sequencing (NGS) and proteomics technologies have enabled various diseases to be characterized at the molecular level to identify new targets and biomarkers to monitor disease progression and treatment efficacy. The analysis of several retinal diseases using NGS and proteomics methods represents a unique opportunity to understand the pathophysiological mechanisms of such diseases and to develop new therapeutic approaches. This Biomedicines Special Issue invites contributions dealing with the identification and characterization of new genes and proteins, and recent advances in the discovery and development of methods in NGS, proteomics, and translation, and their clinical application to retinal diseases. This Special Issue also welcomes articles on transcriptomics research on retinal disease. 

Dr. Jayshree Advani
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• genomics
• proteomics
• biomarker
• variant interpretation
• single-molecule sequencing
• epigenome
• retinal degeneration
• genetics